Low-dose naltrexone (LDN) hope for patients with longCOVID syndrome?

MedExpress.pl
07 August 2022
https://www.medexpress.pl/niskodawkowy-naltrexon-ldn-nadzieja-dla-chorych-z-zespolem-longcovid/85098

Asher Goldstein, MD - LDN Radio Show 2022 (LDN; low dose naltrexone)

Recalcitrant Hailey-Hailey Disease Successfully Treated with Low-dose Naltrexone

J Clin Aesthet Dermatol
November 2020
https://www.academia.edu/79471188/Recalcitrant_Hailey_Hailey_Disease_Successfully_Treated_with_Low_dose_Naltrexone?email_work_card=title

Chronic fatigue: Drug addiction medicine Naltrexone could treat condition

Scilex, a Sorrento Company, Highlights Safety Data From Phase 1 Trial of SP-104, a Proprietary Low Dose Naltrexone for Fibromyalgia

GuruFocus
20 June 2022
https://www.gurufocus.com/news/1770836/scilex-a-sorrento-company-highlights-safety-data-from-phase-1-trial-of-sp104-a-proprietary-low-dose-naltrexone-for-fibromyalgia

What to know about LDN for rheumatoid arthritis

Medical News Today
21 June 2022
https://www.medicalnewstoday.com/articles/ldn-for-rheumatoid-arthritis

Low dose naltrexone (LDN) is a medication. Some researchers believe LDN can help with autoimmune diseases, such as multiple sclerosis, Crohn’s disease, and psoriasis. For this reason, some scientists have looked into the potential efficacy of LDN in treating rheumatoid arthritis (RA).